This study describes the current opportunities and obstacles associated with Medicare Diabetes Prevention Program implementation from the novel perspective of program suppliers across the US.
Hello, everyone. Welcome to today's session. Thank you so much for joining us today. Before we begin, I'd like to cover a few quick notes with you about our webinar platform. Today's webinar will be ...
Objectives Structural MRI of the brain is routinely performed on patients referred to memory clinics; however, resulting radiology reports, including volumetric assessments, are conventionally stored ...
The Association of Southeast Asian Nations (ASEAN) is a state-based membership organisation that facilitates cooperation in Southeast Asia. Over the past two decades, ASEAN has strengthened its ...
In the classic view, DNS, often referred to as the “phone book” of the internet, resolves human-readable internet domain names into IP addresses. Akin to the power grid, DNS is a fundamental part of ...
A new initiative by The Society for Cardiovascular Angiography & Interventions (SCAI) proposes a new framework and call to action for managing cardiogenic shock (CS), establishing lactate clearance ...
Abu Dhabi (UAE): September 19, 2025, (ANI): On his visit to the UAE, Union Minister of Commerce & Industry Piyush Goyal said, "It was a very constructive visit. I go back convinced that the ...
NEWARK, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced the launch of its Agentic Operating Framework, ...
Abstract: The capability to share data across different entities is increasingly pronounced in our data-driven and centric society. However, we also have to ensure properties such as data ...
Abstract: With the rapid development of Internet and mobile technologies, we have witnessed a boom in on-demand service platform operations. Acting as an intermediary between consumers and service ...
Sept 11 (Reuters) - AbbVie shares rose 4% to a record high on Thursday after the U.S. drugmaker said it expected no generic competition for its blockbuster immunology drug Rinvoq until 2037, a ...